Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Indomethacin → 1,8-Naphthyridin-2(1H)-one, 3-methyl-1-phenyl-
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Indomethacin | HCID 3715 | — |
| 반응물 | Propranolol | HCID 4946 | — |
| 반응물 | Pyrilamine | HCID 4992 | — |
| 생성물 | 1,8-Naphthyridin-2(1H)-one, 3-methyl-1-phenyl- | HCID 3087761 | — |
반응 단계
The sensitized guinea pigs are injected i.v. with 1 mg/kg propranolol, 5 mg/kg indomethacin and 2 mg/kg mepyramine given together in a volume of 1 ml/kg. Fifteen minutes later the animals are challenged with nebulized ovalbumin. Test compounds are administered orally 2 hours before challenge with ovalbumin. Suppression of anaphylactic bronchospasm is expressed as a percent inhibition of the peak increase in intratracheal pressure by comparison to a vehicle-treated control group. In this procedure, 3-methyl-1-phenyl-1,8-naphthyridin-2(1H)-one (referred to as Compound A hereinafter) provided a 96% inhibition at a dose of 5 mg/kg p.o.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US04916131 |
| 출처 데이터셋 | uspto-grants-1990_04 |
| ORD ID | ord-1016a1bb331d436f8ac495eb61a53431 |
| 출처 메모 | uspto-grants-1990_04 |